Vaginoscopy Against Standard Treatment (VAST): a Randomised Controlled Trial
Launched by BIRMINGHAM WOMEN'S NHS FOUNDATION TRUST · Oct 25, 2013
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
1. Background
Office hysteroscopy can be associated with significant anxiety, pain and patient dissatisfaction (Clark et al.). One technical modification identified to potentially reduce pain at hysteroscopy is 'vaginoscopy', otherwise known as the 'no touch' technique (Busquets and Lemus, 1993; Clark and Gupta, 2005; Cooper et al., 2010). This describes a technique where the hysteroscope is guided into the uterus without the need for potentially painful vaginal instrumentation. Pain is often experienced by the patient at a number of stages during the standard hysteroscopy practice, the...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Aged 16years or over
- • Referred for diagnostic of operative hysteroscopy in the outpatient setting
- • Written informed consent obtained prior to the hysteroscopy
- Exclusion Criteria:
- • Need for hysteroscopic surgical intervention that requires cervical dilatation e.g. Novasure uterine ablation
About Birmingham Women's Nhs Foundation Trust
Birmingham Women's NHS Foundation Trust is a leading healthcare organization dedicated to providing high-quality women's and neonatal services. Committed to advancing clinical research, the Trust plays a pivotal role in conducting innovative clinical trials that aim to improve health outcomes for women and their families. With a multidisciplinary approach, the Trust collaborates with various stakeholders to ensure rigorous scientific standards and ethical practices are upheld in all research initiatives. Its focus on patient-centered care and commitment to excellence positions Birmingham Women's NHS Foundation Trust as a key contributor to advancements in women's health and medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
Thomas J Clark, MD(hons)
Principal Investigator
Birmingham Women's NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials